The Open Philanthropy Project spoke with Dr. Kesselheim of Harvard Medical School as part of its investigation into research and strategy on improving pharmaceutical research and development (R&D) policy. Conversation topics included the role of the Food and Drug Administration (FDA) in pharmaceutical innovation, factors inhibiting pharmaceutical innovation, potential interventions, and other individuals and organizations working in this area.
